Compound Q&A
What are the main uses of Ibrutinib (CAS: 936563-96-1)?
Answer
Ibrutinib (CAS: 936563-96-1) is primarily used in oncology to treat conditions such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström's macroglobulinemia. It is also prescribed for autoimmune diseases like multiple myeloma and is widely researched for its potential in other therapeutic areas. Its role as a BTK inhibitor makes it significant in targeted cancer therapy.
About
CAS No
936563-96-1
English Name
Ibrutinib
Molecular Formula
C25H24N6O2
Molecular Weight
440.51 g/mol
SMILES
C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
InChIKey
XYFPWWZEPKGCCK-GOSISDBHSA-N
Last Updated: 2025-08-25 01:08
